Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
Maryles Joel Michael
Date
Name
Symbol
Type
Security
Shares
Price
Value
Ownership
Reported
05/24/2022
Chemomab Therapeutics Ltd.
ANCN
Purchase
400
$2.89
$1.2k
05/24/2022
05/24/2022
Chemomab Therapeutics Ltd.
ANCN
Purchase
33
$2.76
$91.1
05/24/2022
03/18/2022
Chemomab Therapeutics Ltd.
ANCN
Purchase
500
$4.32
$2.2k
03/18/2022
03/18/2022
Chemomab Therapeutics Ltd.
ANCN
Purchase
500
$4.36
$2.2k
03/18/2022
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
6.8k
$3.53
$24.1k
03/18/2022
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
6.8k
$3.53
$24.1k
05/24/2022
03/07/2022
Chemomab Therapeutics Ltd.
ANCN
Grant
Option to Purchase American Depositary Shares
6.8k
$3.53
$24.1k
03/07/2022
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
03/07/2022
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
Option to Purchase American Depositary Shares
11.9k
$27.26
$324k
04/19/2021
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
05/24/2022
04/19/2021
Chemomab Therapeutics Ltd.
ANCN
Grant
11.9k
$27.26
$324k
03/18/2022
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy